(Q27002489)

language of work or name

1 reference

November 2013

1 reference

published in

Schizophrenia Bulletin

1 reference

volume

39

1 reference

issue

6

1 reference

page(s)

1174-9

1 reference

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

A meta-analysis of cytokines in major depression

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Meta-analysis of oxidative stress in schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Immune-neural connections: how the immune system's response to infectious agents influences behavior

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Macrophages make me sick: how macrophage activation states influence sickness behavior

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Oxidative stress in schizophrenia: an integrated approach

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Effects of prenatal infection on brain development and behavior: a review of findings from animal models

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Prenatal infection and schizophrenia: a review of epidemiologic and translational studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Early-life programming of later-life brain and behavior: a critical role for the immune system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Immune involvement in schizophrenia and autism: etiology, pathology and animal models

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Altered glutathione redox state in schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Membrane phospholipids and cytokine interaction in schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

A prevalence study of urinary tract infections in acute relapse of schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Neuroinflammation in schizophrenia-related psychosis: a PET study.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796097

Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?

31 May 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Markers of inflammation in the prefrontal cortex of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Karl Jaspers and the genesis of delusions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Minocycline as adjunctive therapy for schizophrenia: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Altered immune function in unaffected first-degree biological relatives of schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBT141

Lower serum interleukin-2 levels in schizophrenic patients with tardive dyskinesia

21 January 2018

1 reference

12 December 2020

Soluble interleukin 2 receptor levels in families of people with schizophrenia

1 reference

12 December 2020

Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes

1 reference

12 December 2020

Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics

1 reference

12 December 2020

Maternal cytokine levels during pregnancy and adult psychosis

1 reference

12 December 2020

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

12 December 2020

Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBT141

1 reference

1 reference

1 reference

PubMed publication ID

24072812

1 reference